OBIO logo

Orchestra BioMed Holdings, Inc.

OBIO
Healthcare|Biotechnology|US
$5.68
+0.06 (+1.07%)
Tangible Book / Share
$0.46
Cash / Share
$1.72
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Nov 6, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (2)

Dec 2026
Est. completion
NAHypertension
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NCT06059638n=316
Oct 2028
Est. completion
NACoronary Artery Disease
Virtue® SAB in the Treatment of Coronary ISR Trial
NCT07045194n=740

Recent Press Releases

Orchestra BioMed Announces Pricing of Public Offering
Nov 5, 2026 · GlobeNewsWire
Orchestra BioMed Announces Virtue SAB Presentation at TCT 2026
Oct 29, 2026 · GlobeNewsWire
Orchestra BioMed to Host R&D Day Featuring Clinical Insights and Development Plans for AVIM Therapy and Virtue® SAB
Oct 22, 2026 · GlobeNewsWire
Orchestra BioMed Exceeds Full Enrollment Target in the BACKBEAT Global Pivotal Trial of AVIM Therapy
Oct 1, 2026 · GlobeNewsWire
OBIO's Capital Access Advisory Program (CAAP®) Reaches Milestone with $1 Billion Raised by High-Growth Life Sciences and Health Tech Ventures
Sep 29, 2026 · Business Wire
Orchestra BioMed Announces AVIM Therapy to Be Featured in Two Sessions at HRX Live 2026
Sep 16, 2026 · GlobeNewsWire
Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics
Sep 15, 2026 · GlobeNewsWire
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 2, 2026 · GlobeNewsWire
Orchestra BioMed to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Aug 27, 2026 · GlobeNewsWire
Orchestra BioMed to Participate in the Wells Fargo 21st Annual Healthcare Conference
Aug 20, 2026 · GlobeNewsWire

SEC Filings (49)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 6, 2026424B5Offering prospectusDocumentIndex
Nov 5, 2026424B5Offering prospectusDocumentIndex
Oct 1, 20268-KMaterial eventDocumentIndex
Sep 8, 20268-KMaterial eventDocumentIndex
Aug 10, 202610-QQuarterly reportDocumentIndex
Jun 23, 20268-KMaterial eventDocumentIndex
Jun 23, 2026S-8Employee stock planDocumentIndex
Jun 16, 2026DEFA14AProxy / shareholder voteDocumentIndex
May 12, 202610-QQuarterly reportDocumentIndex
Apr 29, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Apr 29, 2026ARSAnnual report to holdersDocumentIndex
Apr 29, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 29, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 12, 202610-KAnnual reportDocumentIndex
Feb 27, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 25, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Feb 13, 20268-KMaterial eventDocumentIndex
Feb 6, 2026S-8Employee stock planDocumentIndex
Feb 6, 2026S-8Employee stock planDocumentIndex
Jan 12, 20268-KMaterial eventDocumentIndex
Nov 21, 2025424B3Offering prospectusDocumentIndex
Nov 19, 2025SC 13GPassive 5%+ stakeDocumentIndex
Nov 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 13, 20258-KMaterial eventDocumentIndex
Nov 10, 202510-QQuarterly reportDocumentIndex
Oct 31, 2025S-3Shelf registrationDocumentIndex
Oct 30, 20258-KMaterial eventDocumentIndex
Oct 28, 20258-KMaterial eventDocumentIndex
Aug 12, 202510-QQuarterly reportDocumentIndex
Aug 6, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Aug 4, 20258-KMaterial eventDocumentIndex
Aug 1, 2025424B5Offering prospectusDocumentIndex
Jul 31, 2025424B5Offering prospectusDocumentIndex
Jul 31, 20258-KMaterial eventDocumentIndex
Jun 24, 20258-KMaterial eventDocumentIndex
May 12, 202510-QQuarterly reportDocumentIndex
May 1, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Apr 30, 2025ARSAnnual report to holdersDocumentIndex
Apr 30, 2025DEFA14AProxy / shareholder voteDocumentIndex
Apr 30, 2025DEF 14AProxy / shareholder voteDocumentIndex